id	author	title	date	pages	extension	mime	words	sentences	flesch	summary	cache	txt
cord-289046-frhpt8n9	Fix, Oren K.	Telemedicine and Telehepatology During the COVID‐19 Pandemic	2020-05-21		.txt	text/plain	1474	87	51	The Coronavirus Preparedness and Response Supplemental Appropriations Act (H.R. 6074) was signed into law on March 6, 2020, and provides a temporary waiver of many of the CMS restrictions and requirements regarding telemedicine services during the COVID-19 public health emergency. When these barriers to telemedicine were removed, providers, hospitals, and health systems rapidly embraced telemedicine or scaled up existing programs to meet the sudden demand for remote, synchronous patient care. Some patients with new physical symptoms or recent hepatic decompensation are best evaluated in person but may avoid seeking medical care due to social distancing policies or concerns about exposure to COVID-19 in the health care setting. For established patients with decompensated liver disease, review telemedicine can offer rapid evaluation and avoid the need for an in-person appointment when, for example, adjusting diuretics or medications for hepatic encephalopathy. As we look to a future beyond the COVID-19 pandemic, we have an opportunity to consider telemedicine's place in the routine delivery of patient care.	./cache/cord-289046-frhpt8n9.txt	./txt/cord-289046-frhpt8n9.txt